Real-world evidence of remdesivir in formerly hospitalized COVID-19 patients: patient-reported and functional outcomes

Real-world evidence of remdesivir in formerly hospitalized COVID-19 patients: patient-reported and functional outcomes

Abstract Background Post-COVID condition (PCC) is characterized by persisting symptoms after the resolution of acute COVID-19. Remdesivir (RDV), a broad-spectrum antiviral drug, has been widely used in patients hospitalized with COVID-19 requiring oxygen therapy. We aimed to evaluate the effects of...

Full description

Saved in:
Bibliographic Details
Main Authors: Dorottya Fésü, Enikő Bárczi, Balázs Csoma, Lőrinc Polivka, Márton Boga, Gábor Horváth, János Tamás Varga, Szilvia Sebők, Veronika Müller
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Infectious Diseases
Subjects:
Post-infectious disorders
Post-acute COVID-19 syndrome
Symptom burden
Antiviral agents
Remdesivir
Quality of life
Online Access:https://doi.org/10.1186/s12879-024-10398-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items